Showing results (91-100 of 217) with videos related to

Sort By:
Pageof 22
International Journal of Cancer|May 19, 2005
Wnt2 as a new therapeutic target in malignant pleural mesotheliomaJulien Mazieres, Liang You, Biao He, et al.
Diagnostics (Basel, Switzerland)|November 6, 2020
Prospective Evaluation of Single Nucleotide Variants by Two Different Technologies in Paraffin Samples of Advanced Non-Small Cell Lung Cancer PatientsElba Marin, Roxana Reyes, Ainara Arcocha, et al.
JTO Clinical and Research Reports|May 11, 2023
Incidence of Bone Metastases and Skeletal-Related Events in Patients With EGFR-Mutated NSCLC Treated With OsimertinibAnita J W M Brouns, Ard van Veelen, G D Marijn Veerman, et al.
Nature Reviews. Clinical Oncology|July 24, 2023
Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challengesGiannis Mountzios, Jordi Remon, Lizza E L Hendriks, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2023
Survival of patients with KRAS G12C mutated stage IV non-small cell lung cancer with and without brain metastases treated with immune checkpoint inhibitorsEsther M Swart, Anneloes L Noordhof, Ronald A M Damhuis, et al.
Cancer Research|February 12, 2005
Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cellsBiao He, Amie Y Lee, Sina Dadfarmay, et al.
Cancer Research|July 17, 2004
Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancerJulien Mazieres, Biao He, Liang You, et al.
Frontiers in Oncology|January 24, 2022
Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune TherapyEvelien A J van Genugten, Jetty A M Weijers, Sandra Heskamp, et al.
European Journal of Cancer (Oxford, England : 1990)|June 10, 2026
Efficacy of alectinib for ALK-positive NSCLC according to tumor burden and body mass index: A pooled analysis of the randomized phase III trials ALEX and J-ALEXMarco Tagliamento, Marco Bruzzone, Eva Blondeaux, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2019
Defining oligometastatic non-small cell lung cancer: A simulated multidisciplinary expert opinionLizza E L Hendriks, Christophe Dooms, Thierry Berghmans, et al.
Pageof 22